A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If ...
DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.
7hon MSN
Single-dose base editing corrects PKD1 mutation and extends survival in ADPKD preclinical models
Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible ...
Gene-editing techniques — and particularly base editing, which allows precise editing of single nucleotides — have the potential to correct many disease-causing genetic variants. However, efforts to ...
Scientists at the National Institutes of Health (NIH) have successfully reduced the severity of late-onset Tay-Sachs (LOTS) disease in human cell cultures and a mouse model by using a novel ...
Cardiovascular disease is the world’s leading killer and one of the most economically damaging, as its prevalence and costs have been rising. According to our research, offering a one-time ...
Please provide your email address to receive an email when new articles are posted on . A gene-editing therapy targeting ANGPTL3 did not cause serious adverse events in an early study. Higher doses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results